Clinical Trials Directory

Trials / Conditions / Epidermolysis Bullosa, Junctional

Epidermolysis Bullosa, Junctional

7 registered clinical trials studyying Epidermolysis Bullosa, Junctional — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis
NCT06917690
Chiesi Farmaceutici S.p.A.Phase 3
RecruitingA Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
NCT06423573
Amryt Pharma—
UnknownCACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa
NCT06007235
Organ, Tissue, Regeneration, Repair and ReplacementN/A
CompletedINM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa
NCT04908215
InMed Pharmaceuticals Inc.Phase 2
UnknownThe State of Sexual Development in Children With Inherited Epidermolysis Bullosa
NCT05033574
National Medical Research Center for Children's Health, Russian Federation—
UnknownComputational Drug Repurposing for All EBS Cases
NCT03269474
Joyce Teng—
TerminatedSafety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis B
NCT00587223
OrganogenesisPhase 3